Levea C - Search Results

1

Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinoma.

Khoury T, Chadha K, Javle M, Donohue K, Levea C, Iyer R, Okada H, Nagase H, Tan D. Khoury T, et al. Among authors: levea c. Int J Gastrointest Cancer. 2005;35(3):171-7. doi: 10.1385/IJGC:35:3:171. Int J Gastrointest Cancer. 2005. PMID: 16110118

2

Nuclear survivin expression predicts poor outcome in cholangiocarcinoma.

Javle MM, Tan D, Yu J, LeVea CM, Li F, Kuvshinoff BW, Gibbs JF. Javle MM, et al. Hepatogastroenterology. 2004 Nov-Dec;51(60):1653-7. Hepatogastroenterology. 2004. PMID: 15532797

3

Anaplastic pancreatic carcinoma. A case report and review of literature.

Chadha MK, LeVea C, Javle M, Kuvshinoff B, Vijaykumar R, Iyer R. Chadha MK, et al. Among authors: levea c. JOP. 2004 Nov 10;5(6):512-5. JOP. 2004. PMID: 15536293 Review.

4

COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.

Foster J, Black J, LeVea C, Khoury T, Kuvshinoff B, Javle M, Gibbs JF. Foster J, et al. Among authors: levea c. Ann Surg Oncol. 2007 Feb;14(2):752-8. doi: 10.1245/s10434-006-9123-8. Epub 2006 Dec 5. Ann Surg Oncol. 2007. PMID: 17146741

5

CD24 expression is an independent prognostic marker in cholangiocarcinoma.

Agrawal S, Kuvshinoff BW, Khoury T, Yu J, Javle MM, LeVea C, Groth J, Coignet LJ, Gibbs JF. Agrawal S, et al. Among authors: levea c. J Gastrointest Surg. 2007 Apr;11(4):445-51. doi: 10.1007/s11605-007-0091-5. J Gastrointest Surg. 2007. PMID: 17436128 Free PMC article.

6

Epidermal growth factor receptor-directed therapy in esophageal cancer.

Pande AU, Iyer RV, Rani A, Maddipatla S, Yang GY, Nwogu CE, Black JD, Levea CM, Javle MM. Pande AU, et al. Among authors: levea cm. Oncology. 2007;73(5-6):281-9. doi: 10.1159/000132393. Epub 2008 May 14. Oncology. 2007. PMID: 18477853 Review.

7

Pilot study of gefitinib, oxaliplatin, and radiotherapy for esophageal adenocarcinoma: tissue effect predicts clinical response.

Javle M, Pande A, Iyer R, Yang G, LeVea C, Wilding G, Black J, Nava H, Nwogu C. Javle M, et al. Among authors: levea c. Am J Clin Oncol. 2008 Aug;31(4):329-34. doi: 10.1097/COC.0b013e318161dc04. Am J Clin Oncol. 2008. PMID: 18845990 Clinical Trial.

8

Capecitabine, oxaliplatin and radiotherapy: a phase IB neoadjuvant study for esophageal cancer with gene expression analysis.

Javle MM, Yang G, Nwogu CE, Wilding GE, O'Malley L, Vinjamaram S, Schiff MD, Nava HR, LeVea C, Clark KR, Prey JD, Smith PF, Pendyala L. Javle MM, et al. Among authors: levea c. Cancer Invest. 2009 Feb;27(2):193-200. doi: 10.1080/07357900802172093. Cancer Invest. 2009. PMID: 19235592 Clinical Trial.

9

Metastatic pancreatic adenocarcinoma and renal cell carcinoma treated with gemcitabine and sunitinib malate. A case report.

Bharthuar A, Pearce L, Litwin A, LeVea C, Kuvshinoff B, Iyer R. Bharthuar A, et al. Among authors: levea c. JOP. 2009 Sep 4;10(5):523-7. JOP. 2009. PMID: 19734629

10

Surgical resection after TNFerade therapy for locally advanced pancreatic cancer.

Chadha MK, Litwin A, Levea C, Iyer R, Yang G, Javle M, Gibbs JF. Chadha MK, et al. Among authors: levea c. JOP. 2009 Sep 4;10(5):535-8. JOP. 2009. PMID: 19734632

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters